Last reviewed · How we verify

NCT06692517

Benchmarks in Elective Laparoscopic Cholecystectomy

Completed Last updated 31 December 2024
What this trial tests

trial testing Laparoscopic cholecystectomy in Gall Stone in 60,000 participants. Completed in 31 December 2023.

Timeline
1 January 2015
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorRegion Östergötland
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60,000
Start date1 January 2015
Primary completion31 December 2023
Estimated completion31 December 2023

Drugs / interventions tested

Conditions studied

Sponsor

Region Östergötland

Who can join

18 and older, any sex, with Gall Stone or Gallbladder Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational cohort study is to define peri- and postoperative reference values for elective laparoscopic cholecystectomy, using the achievable benchmarks of care methodology (ABC™). Another aim is to develop adjusted reference values for groups with a risk factor of severe postoperative complications. The over-arching aim is to inspire quality improvement initiatives.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Laparoscopic cholecystectomy

Trials testing the same drug.

Other recruiting trials for Gall Stone

Currently open trials in the same condition.

Other Region Östergötland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06692517.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing